Clinical Trial Update: Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. [NA]

View source ↗

Summary

The document is a clinical trial update on the safety and antiviral study of ACH-126, 443 (Beta-L-Fd4C) in adults with chronic hepatitis B. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ACH-126, 443 (Beta-L-Fd4C)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Chronic Hepatitis B | NA | Status: TERMINATED